Screener
Kestra Medical Technologies KMTS Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Kestra Medical Technologies in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 5:16 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001193125-26-303397
| Line item | Year Ended April 30, 2026 | Year Ended April 30, 2025 |
|---|---|---|
| Other expense (income) | (2,618) | 2,766 |
| Net loss before provision for income taxes | (131,318) | (113,679) |
| Provision for income taxes | 294 | 135 |
| Net loss | (131,612) | (113,814) |
| Less: Undeclared preferred stock dividends | — | 12,321 |
| Net loss attributable to common shareholders, basic and diluted | $(131,612) | $(126,135) |
| Net loss per share attributable to common shareholders, basic and diluted | $(2.43) | $(5.13) |
| Weighted-average shares of common shares outstanding, basic and diluted1 | 54,184,698 | 24,583,745 |
Item 16. Form 10-K Summary.
FAQ
- What is Kestra Medical Technologies's net income?
- Kestra Medical Technologies (KMTS) reported net income of -$38.84M in Q1 2026.
- How has Kestra Medical Technologies's net income changed year-over-year?
- Kestra Medical Technologies's net income increased by 25.4% year-over-year, from -$52.05M to -$38.84M.
- What is the long-term trend for Kestra Medical Technologies's net income?
- Over 2 years (2024 to 2026), Kestra Medical Technologies's net income has grown at a 18.3% compound annual growth rate (CAGR), from -$94.12M to -$131.61M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Kestra Medical Technologies's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude